XML 36 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Organization, Basis of Presentation, and Summary of Significant Accounting Policies (Details Textual)
1 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended 12 Months Ended
Nov. 22, 2017
USD ($)
Jul. 03, 2017
USD ($)
May 05, 2017
USD ($)
Mar. 01, 2017
Dec. 27, 2016
USD ($)
Jul. 31, 2018
USD ($)
Nov. 26, 2017
USD ($)
Nov. 27, 2016
USD ($)
Nov. 22, 2017
USD ($)
Nov. 26, 2017
USD ($)
Nov. 27, 2016
USD ($)
May 28, 2017
USD ($)
Jul. 15, 2014
Number of Proprietary Platforms             2     2      
Debt Issuance Costs, Current, Net             $ 60,000     $ 60,000   $ 60,000  
Debt Issuance Costs, Noncurrent, Net             171,000     171,000   201,000  
Legal Actions Against Apio [Member]                          
Loss Contingency Accrual             $ 1,000,000     $ 1,000,000   $ 3,200,000  
Unfair Labor Practice Claims [Member]                          
Litigation Settlement, Amount Awarded to Other Party         $ 310,000                
Discrimination and Wrongful Termination and Wage and Hour Claims [Member]                          
Litigation Settlement, Amount Awarded to Other Party $ 1,800,000   $ 6,000,000     $ 1,800,000              
Payments for Legal Settlements   $ 2,400,000             $ 4,200,000        
Apio [Member] | Legal Actions Against Apio [Member]                          
Loss Contingency, Number of Plaintiffs                   100      
Apio [Member] | Unfair Labor Practice Claims [Member]                          
Litigation Settlement, Amount Awarded to Other Party         $ 155,000                
HA Based Biomaterials [Member]                          
Number of Product Segments                   3      
HA Based Biomaterials [Member] | Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Ophthalmic [Member]                          
Concentration Risk, Percentage                       65.00%  
HA Based Biomaterials [Member] | Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Orthopedic [Member]                          
Concentration Risk, Percentage                       15.00%  
HA Based Biomaterials [Member] | Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member] | Other/Non-HA [Member]                          
Concentration Risk, Percentage                       20.00%  
Windset [Member]                          
Investment Ownership Percentage             26.90%     26.90%     26.90%
Apio Cooling, LP [Member]                          
Business Acquisition, Percentage of Voting Interests Acquired             60.00%     60.00%      
Pacific Harvest [Member] | Discrimination and Wrongful Termination and Wage and Hour Claims [Member]                          
Litigation Settlement, Amount to be Reimbursed                 $ 2,100,000        
O Olive [Member]                          
Finite-Lived Intangible Asset, Useful Life       11 years                  
Business Combination, Contingent Consideration, Liability             $ 5,400,000     $ 5,400,000   $ 5,900,000  
Contingent Consideration Payment Period       3 years           3 years      
Customer Relationships [Member] | Minimum [Member]                          
Finite-Lived Intangible Asset, Useful Life                   11 years      
Customer Relationships [Member] | Maximum [Member]                          
Finite-Lived Intangible Asset, Useful Life                   13 years      
Prepaid Expenses and Other Current Assets [Member]                          
Debt Issuance Costs, Line of Credit Arrangements, Net             120,000     $ 120,000   120,000  
Other Assets [Member]                          
Debt Issuance Costs, Line of Credit Arrangements, Net             338,000     338,000   399,000  
Windset [Member]                          
Accounts Receivable, Related Parties, Current             109,000     109,000   $ 388,000  
Windset [Member] | Cost of Sales [Member]                          
Revenue from Related Parties             $ 91,000 $ 75,000   $ 195,000 $ 193,000